Wamilda, Jerillo R.

HRN: 28-56-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/11/2026
02/11/2026
IVT
1GM
ON CALL TO OR
LTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines